Related Experiment Video
Updated: Jul 15, 2026

06:59
Characterization of Metabolic Status in Nonhuman Primates with the Intravenous Glucose Tolerance Test
Published on: November 13, 2016
Hypothyroidism in an African forest buffalo (Syncerus caffer nanus)
Matthew C Allender1, Michael Briggs, Clifford F Shipley
1University of Illinois, College of Veterinary Medicine, Urbana 61802, USA.
Summary
A hypothyroid African forest buffalo with hoof overgrowth and reproductive issues improved after levothyroxine treatment. This study highlights thyroid hormone
Area of Science:
- Veterinary Medicine
- Endocrinology
- Wildlife Biology
Background:
- African forest buffalo (Syncerus caffer nanus) are large herbivores native to Central and West Africa.
- Thyroid hormones, including total triiodothyronine (TT3) and total thyroxine (TT4), are crucial for regulating metabolism, growth, and reproduction in mammals.
Observation:
- An adult female African forest buffalo presented with recurrent hoof overgrowth, persistent anestrous, obesity, dull hair coat, and decreased activity.
- Routine blood work and serum biochemistry were within normal limits.
- Blood analysis revealed decreased concentrations of total triiodothyronine and total thyroxine compared to reference values.
Findings:
- Treatment with oral levothyroxine normalized thyroid hormone levels (TT3 and TT4).
- The buffalo showed significant clinical improvement, including weight loss, improved hair coat, and resumption of reproductive cycling.
Implications:
- This case demonstrates the successful diagnosis and treatment of hypothyroidism in an African forest buffalo.
- Levothyroxine therapy can effectively manage metabolic and reproductive disturbances associated with hypothyroidism in this species.
- Findings suggest the importance of considering thyroid dysfunction in the differential diagnosis of similar clinical signs in exotic ungulates.
More Related Videos
Related Concept Videos
Hypothyroidism II: Pathophysiology
Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Cushing Syndrome II: Pathophysiology
Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Graves' Disease I: Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...

